Literature DB >> 11591369

Interaction of bepridil with the cardiac troponin C/troponin I complex.

E Abusamhadneh1, M B Abbott, A Dvoretsky, N Finley, S Sasi, P R Rosevear.   

Abstract

We have investigated the binding of bepridil to calcium-saturated cardiac troponin C in a cardiac troponin C/troponin I complex. Nuclear magnetic resonance spectroscopy and [(15)N,(2)H]cardiac troponin C permitted the mapping of bepridil-induced amide proton chemical shifts. A single bepridil-binding site in the regulatory domain was found with an affinity constant of approximately 140 microM(-1). In the presence of cardiac troponin I, bepridil binding to the C domain of cardiac troponin C was not detected. The pattern of bepridil-induced chemical shifts is consistent with stabilization of more open regulatory domain conformational states. A similar pattern of chemical shift perturbations was observed for interaction of the troponin I cardiac-specific amino-terminus with the cardiac troponin C regulatory domain. These results suggest that both bepridil and the cardiac-specific amino-terminus may mediate an increase in calcium affinity by interacting with and stabilizing open regulatory domain conformations. Chemical shift mapping suggests a possible role for inactive calcium-binding site I in the modulation of calcium affinity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11591369     DOI: 10.1016/s0014-5793(01)02790-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  6 in total

1.  Fluorescence Based Characterization of Calcium Sensitizer Action on the Troponin Complex.

Authors:  William Schlecht; King-Lun Li; Dehong Hu; Wenji Dong
Journal:  Chem Biol Drug Des       Date:  2015-09-16       Impact factor: 2.817

Review 2.  Structural based insights into the role of troponin in cardiac muscle pathophysiology.

Authors:  Monica X Li; Xu Wang; Brian D Sykes
Journal:  J Muscle Res Cell Motil       Date:  2005-02-09       Impact factor: 2.698

Review 3.  Interaction of cardiac troponin with cardiotonic drugs: a structural perspective.

Authors:  Monica X Li; Ian M Robertson; Brian D Sykes
Journal:  Biochem Biophys Res Commun       Date:  2007-12-26       Impact factor: 3.575

4.  A computational and experimental approach to investigate bepridil binding with cardiac troponin.

Authors:  Jayson F Varughese; Tamatha Baxley; Joseph M Chalovich; Yumin Li
Journal:  J Phys Chem B       Date:  2011-02-18       Impact factor: 2.991

Review 5.  The contractile apparatus as a target for drugs against heart failure: interaction of levosimendan, a calcium sensitiser, with cardiac troponin c.

Authors:  Tia Sorsa; Piero Pollesello; R John Solaro
Journal:  Mol Cell Biochem       Date:  2004-11       Impact factor: 3.396

6.  Uncoupling of myofilament Ca2+ sensitivity from troponin I phosphorylation by mutations can be reversed by epigallocatechin-3-gallate.

Authors:  Maria Papadaki; Petr G Vikhorev; Steven B Marston; Andrew E Messer
Journal:  Cardiovasc Res       Date:  2015-06-24       Impact factor: 10.787

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.